APG Asset Management
IRWD icon

APG Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

APG Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-187,800
Closed -$2.12M – 912
2022
Q1 		$2.12M Buy
187,800
+110,700
+144% +$1.27M ﹤0.01% 557
2021
Q4 		$791K Sell
77,100
-79,900
-51% -$980K ﹤0.01% 770
2021
Q3 		$1.77M Buy
157,000
+33,100
+27% +$428K ﹤0.01% 644
2021
Q2 		$1.34M Buy
+123,900
New +$1.42M ﹤0.01% 731
2020
Q4 		– Sell
-24,200
Closed -$186K – 988
2020
Q3 		$186K Buy
+24,200
New +$241K ﹤0.01% 973

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

APG Asset Management's IRWD Position: Q2 2022 in Review

APG Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 187,800 shares — an estimated $2.12M sold.

APG Asset Management first reported a position in IRWD in Q3 2020 and held it in 5 quarters. The position peaked at $2.12M in Q1 2022. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • APG Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • APG Asset Management sold 187,800 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $2.12M.
  • APG Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 5 quarters.
  • APG Asset Management's Ironwood Pharmaceuticals position peaked at $2.12M in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on APG Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.